Dr. Robert W. Coombs

powered by
COS Expertise®
University of Washington
School of Medicine
Laboratory Medicine
Allergy and Infectious Diseases
ProfessorAppointed: 1995

Mailing Address

Harborview Medical Center
UW Virology Division
325 9th Ave.
Box 359690 HMC, R&T Bldg., Rm.706
Seattle, Washington 98104
United States

Contact Information

Phone: (206) 897-5200
Fax: (206) 897-5203
bcoombs@u.washington.edu

Qualifications

M.D., Dalhousie University, 1981.
Ph.D., Dalhousie University, 1977.

Keywords

COS Keywords:

AIDS, Disease Prevention, HIV, HIV Prevention, Infectious Diseases Or Agents, Laboratory Practice or Procedure, Preventive Medicine, Virology.

Additional Terms:

AIDS, Disease Manifestation, HIV/SIV Infection, Infectious Diseases, Treatment/Prevention.

Publications

  • Speck CE, Coombs RW, Koutsky LA, Zeh J, Ross SO, Hooton TM, Collier AC, Corey L, Cent A, Dragavon J, Lee W, Johnson EJ, Sampoleo RR, Krieger JN, Risk factors for HIV-1 shedding in semen., American Journal of Epidemiology, 150(6), 622-31, 15 Sep 1999 Abstract
  • Panther LA, Coombs RW, Aung SA, dela Rosa C, Gretch D, Corey L, Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells: relative effect of recombinant CD4, zidovudine, and saquinavir in vitro., Journal of Medical Virology, 58(2), 165-73, June 1999 Abstract
  • Li W, Coombs RW, Collier AC, Raisys VA, Determination of indinavir, a HIV-1 protease inhibitor, in human plasma using ion-pair reversed-phase high-performance liquid chromatography., Therapeutic Drug Monitoring, 21(3), 360-6, June 1999 Abstract
  • Melvin AJ, Rodrigo AG, Mohan KM, Lewis PA, Manns-Arcuino L, Coombs RW, Mullins JI, Frenkel LM, HIV-1 dynamics in children., Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20(5), 468-73, 15 Apr 1999 Abstract
  • Lew J, Reichelderfer P, Fowler M, Bremer J, Carrol R, Cassol S, Chernoff D, Coombs R, Cronin M, Dickover R, Fiscus S, Herman S, Jackson B, Kornegay J, Kovacs A, McIntosh K, Meyer W, Michael N, Mofenson L, Moye J, Quinn T, Robb M, Vahey M, Weiser B, Yeghiazarian T, Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blo, Journal of Clinical Microbiology, 36(6), 1471-9, June 1998 Abstract
  • Reichelderfer PS, Coombs RW, Cartesian coordinate analysis of viral burden and CD4+ T-cell count in human immunodeficiency virus type-1 infection., Antiviral Research, 38(3), 181-94, June 1998 Abstract
  • Schacker T W, Hughes J P, Shea T, Coombs R W, Corey L, Biological and virologic characteristics of primary HIV infection., Annals of Internal Medicine, 128(8), 613-20, 15 Apr 1998 Abstract
  • Schacker TW, Hughes JP, Shea T, Coombs RW, Corey L, Biological and virologic characteristics of primary HIV infection [see comments, Annals of Internal Medicine, 128(8), 613-20, 15 1998 Abstract
  • Panther L A, Coombs R W, Zeh J E, Collier A C, Corey L, Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression t, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 17(4), 303-13, 1 Apr 1998 Abstract
  • Eastman P S, Shapiro D E, Coombs R W, Frenkel L M, McSherry G D, Britto P, Herman S A, Sperling R S, Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials G, Journal of Infectious Diseases, 177(3), 557-64, March 1998 Abstract
  • Krieger J N, Nirapathpongporn A, Chaiyaporn M, Peterson G, Nikolaeva I, Akridge R, Ross S O, Coombs R W, Vasectomy and human immunodeficiency virus type 1 in semen., Journal of Urology, 159(3), 820-5; discussion 82, March 1998 Abstract
  • Coombs R W, Speck C E, Hughes J P, Lee W, Sampoleo R, Ross S O, Dragavon J, Peterson G, Hooton T M, Collier A C, Corey L, Koutsky L, Krieger J N, Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood., Journal of Infectious Diseases, 177(2), 320-30, February 1998 Abstract
  • Muller C H, Coombs R W, Krieger J N, Effects of clinical stage and immunological status on semen analysis results in human immunodeficiency virus type 1-seropositive men., Andrologia, 30 Suppl 1, 15-22, 1998 Abstract
  • Brambilla D, Leung S, Lew J, Todd J, Herman S, Cronin M, Shapiro D E, Bremer J, Hanson C, Hillyer G V, McSherry G D, Sperling R S, Coombs R W, Reichelderfer P S, Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons., Journal of Clinical Microbiology, 36(1), 311-4, Jan 1998 Abstract
  • Marschner I C, Collier A C, Coombs R W, D'Aquila R T, DeGruttola V, Fischl M A, Hammer S M, Hughes M D, Johnson V A, Katzenstein D A, Richman D D, Smeaton L M, Spector S A, Saag M S, Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy., Journal of Infectious Diseases, 177(1), 40-7, Jan 1998 Abstract
  • Vanhove G F, Gries J M, Verotta D, Sheiner L B, Coombs R, Collier A C, Blaschke T F, Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy., Antimicrobial Agents and Chemotherapy, 41(11), 2433-8, November 1997 Abstract
  • Diamond C, Huang M L, Kedes D H, Speck C, Rankin G W Jr, Ganem D, Coombs R W, Rose T M, Krieger J N, Corey L, Absence of detectable human herpesvirus 8 in the semen of human immunodeficiency virus-infected men without Kaposi's sarcoma., Journal of Infectious Diseases, 176(3), 775-7, September 1997 Abstract
  • Melvin A J, Burchett S K, Watts D H, Hitti J, Hughes J P, McLellan C L, King P D, Johnson E J, Williams B L, Frenkel L M, Coombs R W, Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected women., Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 14(3), 232-6, 1 Mar 1997 Abstract
  • Paxton W B, Coombs R W, McElrath M J, Keefer M C, Hughes J, Sinangil F, Chernoff D, Demeter L, Williams B, Corey L, Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with > or = 400 CD4 lymphocytes: implications for applying measurements to individual patient, Journal of Infectious Diseases, 175(2), 247-54, February 1997 Abstract
  • Sperling R S, Shapiro D E, Coombs R W, Todd J A, Herman S A, McSherry G D, O'Sullivan M J, Van Dyke R B, Jimenez E, Rouzioux C, Flynn P M, Sullivan J L, Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group [see, New England Journal of Medicine, 335(22), 1621-9, 28 Nov 1996 Abstract
  • Yen-Lieberman B, Brambilla D, Jackson B, Bremer J, Coombs R, Cronin M, Herman S, Katzenstein D, Leung S, Lin H J, Palumbo P, Rasheed S, Todd J, Vahey M, Reichelderfer P, Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories., Journal of Clinical Microbiology, 34(11), 2695-701, November 1996 Abstract
  • Coombs R W, Welles S L, Hooper C, Reichelderfer P S, D'Aquila R T, Japour A J, Johnson V A, Kuritzkes D R, Richman D D, Kwok S, Todd J, Jackson J B, DeGruttola V, Crumpacker C S, Kahn J, Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG V, Journal of Infectious Diseases, 174(4), 704-12, October 1996 Abstract
  • Welles S L, Jackson J B, Yen-Lieberman B, Demeter L, Japour A J, Smeaton L M, Johnson V A, Kuritzkes D R, D'Aquila R T, Reichelderfer P A, Richman D D, Reichman R, Fischl M, Dolin R, Coombs R W, Kahn J O, McLaren C, Todd J, Kwok S, Crumpacker C S, Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Pro, Journal of Infectious Diseases, 174(4), 696-703, October 1996 Abstract
  • Scott W A, Brambilla D, Siwak E, Beatty C, Bremer J, Coombs R W, Farzadegan H, Fiscus S A, Hammer S M, Hollinger F B, Khan N, Rasheed S, Reichelderfer P S, Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Gr, Journal of Clinical Microbiology, 34(9), 2312-5, September 1996 Abstract
  • Saag M S, Holodniy M, Kuritzkes D R, O'Brien W A, Coombs R, Poscher M E, Jacobsen D M, Shaw G M, Richman D D, Volberding P A, HIV viral load markers in clinical practice., Nature Medicine, 2(6), 625-9, June 1996 Abstract
  • Collier A C, Coombs R W, Schoenfeld D A, Bassett R L, Timpone J, Baruch A, Jones M, Facey K, Whitacre C, McAuliffe V J, Friedman H M, Merigan T C, Reichman R C, Hooper C, Corey L, Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group., New England Journal of Medicine, 334(16), 1011-7, 18 Apr 1996 Abstract
  • Klebanoff S J, Coombs R W, Virucidal effect of stimulated eosinophils on human immunodeficiency virus type 1., Aids Research and Human Retroviruses, 12(1), 25-9, 1 Jan 1996 Abstract
  • Collier A C, Coombs R W, Schoenfeld D A, Bassett R, Baruch A, Corey L, Combination therapy with zidovudine, didanosine and saquinavir., Antiviral Research, 29(1), 99, January 1996 Abstract
  • Reichelderfer P S, Coombs R W, Cartesian coordinate analysis of viral burden and CD4+ cell count in HIV disease: implications for clinical trial design and analysis., Antiviral Research, 29(1), 83-6, January 1996 Abstract
  • Collier A C, Coombs R W, Katzenstein D, Holodniy M, Gibson J, Mordenti J, Izu A E, Duliege A M, Ammann A J, Merigan T, et al, Safety, pharmacokinetics, and antiviral response of CD4-immunoglobulin G by intravenous bolus in AIDS and AIDS-related complex., Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10(2), 150-6, 1 Oct 1995 Abstract
  • Krieger J N, Coombs R W, Collier A C, Ho D D, Ross S O, Zeh J E, Corey L, Intermittent shedding of human immunodeficiency virus in semen: implications for sexual transmission., Journal of Urology, 154(3), 1035-40, September 1995 Abstract
  • Schacker T, Collier A C, Coombs R, Unadkat J D, Fox I, Alam J, Wang J P, Eggert E, Corey L, Phase I study of high-dose, intravenous rsCD4 in subjects with advanced HIV-1 infection., Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 9(2), 145-52, 1 Jun 1995 Abstract
  • Frenkel L M, Wagner L E 2nd, Demeter L M, Dewhurst S, Coombs R W, Murante B L, Reichman R C, Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1., Clinical Infectious Diseases, 20(5), 1321-6, May 1995 Abstract
  • Japour A J, Welles S, D'Aquila R T, Johnson V A, Richman D D, Coombs R W, Reichelderfer P S, Kahn J O, Crumpacker C S, Kuritzkes D R, Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117, Journal of Infectious Diseases, 171(5), 1172-9, May 1995 Abstract
  • Krieger J N, Coombs R W, Collier A C, Ross S O, Speck C, Corey L, Seminal shedding of human immunodeficiency virus type 1 and human cytomegalovirus: evidence for different immunologic controls., Journal of Infectious Diseases, 171(4), 1018-22, April 1995 Abstract
  • D'Aquila R T, Johnson V A, Welles S L, Japour A J, Kuritzkes D R, DeGruttola V, Reichelderfer P S, Coombs R W, Crumpacker C S, Kahn J O, et al, Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group., Annals of Internal Medicine, 122(6), 401-8, 15 Mar 1995 Abstract
  • Fiscus S A, DeGruttola V, Gupta P, Katzenstein D A, Meyer W A 3rd, LoFaro M L, Katzman M, Ragni M V, Reichelderfer P S, Coombs R W, Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial., Journal of Infectious Diseases, 171(2), 305-11, February 1995 Abstract
  • Reichelderfer P S, Coombs R W, Virologic parameters as surrogate markers for clinical outcome in HIV-1 disease: verification, variation, and validation., Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10 Suppl 2, S19-24, 1995 Abstract
  • Coombs R W, HIV-1 burden as a marker of disease progression and clinical response to therapy in AIDS., Clinics In Laboratory Medicine, 14(2), 301-11, June 1994 Abstract
  • Celum C L, Coombs R W, Jones M, Murphy V, Fisher L, Grant C, Corey L, Inui T, Wener M H, Holmes K K, Risk factors for repeatedly reactive HIV-1 EIA and indeterminate western blots. A population-based case-control study., Archives of Internal Medicine, 154(10), 1129-37, 23 May 1994 Abstract
  • DeGruttola V, Beckett L A, Coombs R W, Arduino J M, Balfour H H Jr, Rasheed S, Hollinger F B, Fischl M A, Volberding P, Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. Aids Clinical Trials Group Virology Laboratories., Journal of Infectious Diseases, 169(4), 713-21, April 1994 Abstract
  • Shafer R W, Kozal M J, Winters M A, Iversen A K, Katzenstein D A, Ragni M V, Meyer W A 3rd, Gupta P, Rasheed S, Coombs R, et al, Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations., Journal of Infectious Diseases, 169(4), 722-9, April 1994 Abstract
  • Fischl M A, Resnick L, Coombs R, Kremer A B, Pottage J C Jr, Fass R J, Fife K H, Powderly W G, Collier A C, Aspinall R L, et al, The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3., Journal of Acquired Immune Deficiency Syndromes, 7(2), 139-47, February 1994 Abstract
  • Schacker T, Coombs R W, Collier A C, Zeh J E, Fox I, Alam J, Nelson K, Eggert E, Corey L, The effects of high-dose recombinant soluble CD4 on human immunodeficiency virus type 1 viremia., Journal of Infectious Diseases, 169(1), 37-40, January 1994 Abstract
  • Collier A C, Coombs R W, Fischl M A, Skolnik P R, Northfelt D, Boutin P, Hooper C J, Kaplan L D, Volberding P A, Davis L G, et al, Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection., Annals of Internal Medicine, 119(8), 786-93, 15 Oct 1993 Abstract
  • Coombs R W, Henrard D R, Mehaffey W F, Gibson J, Eggert E, Quinn T C, Phillips J, Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction., Journal of Clinical Microbiology, 31(8), 1980-6, August 1993 Abstract
  • Frumkin L R, Agy M B, Coombs R W, Panther L, Morton W R, Koehler J, Florey M J, Dragavon J, Schmidt A, Katze M G, et al, Acute infection of Macaca nemestrina by human immunodeficiency virus type 1., Virology, 195(2), 422-31, August 1993 Abstract
  • Claypoole K H, Townes B D, Collier A C, Marra C, Longstreth W T Jr, Cohen W, Martin D, Coombs R W, Goldstein D, Sanchez P, et al, Cognitive risk factors and neuropsychological performance in HIV infection., International Journal of Neuroscience, 70(1-2), 13-27, May 1993 Abstract
  • Compton S J, Celum C L, Lee C, Thompson D, Sumi S M, Fritsche T R, Coombs R W, Trichinosis with ventilatory failure and persistent myocarditis., Clinical Infectious Diseases, 16(4), 500-4, April 1993 Abstract
  • Cooney E L, McElrath M J, Corey L, Hu S L, Collier A C, Arditti D, Hoffman M, Coombs R W, Smith G E, Greenberg P D, Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp16, Proceedings of the National Academy of Sciences (USA), 90(5), 1882-6, 1 Mar 1993 Abstract
  • Corey L, Coombs R W, The natural history of HIV infection: implications for the assessment of antiretroviral therapy., Clinical Infectious Diseases, 16 Suppl 1, S2-6, February 1993 Abstract
  • Celum C L, Coombs R W, Indeterminate HIV-1 western blots: implications and considerations for widespread HIV testing., Journal of General Internal Medicine, 7(6), 640-5, Autumn 1992 Abstract
  • Agy M B, Frumkin L R, Corey L, Coombs R W, Wolinsky S M, Koehler J, Morton W R, Katze M G, Infection of Macaca nemestrina by human immunodeficiency virus type-1., Science, 257(5066), 103-6, 3 Jul 1992 Abstract
  • Cohen W A, Maravilla K R, Gerlach R, Claypoole K, Collier A C, Marra C, Maxwell C, Coombs R W, Longstreth W T Jr, Townes B D, et al, Prospective cerebral MR study of HIV seropositive and seronegative men: correlation of MR findings with neurologic, neuropsychologic, and cerebrospinal fluid analysis., AJNR American Journal of Neuroradiology, 13(4), 1231-40, Summer 1992 Abstract
  • Riddell S R, Greenberg P D, Overell R W, Loughran T P, Gilbert M J, Lupton S D, Agosti J, Scheeler S, Coombs R W, Corey L, Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Ca, Human Gene Therapy, 3(3), 319-38, June 1992 Abstract
  • Klebanoff S J, Coombs R W, Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1. Role of the myeloperoxidase system., Journal of Clinical Investigation, 89(6), 2014-7, June 1992 Abstract
  • Agosti J M, Coombs R W, Collier A C, Paradise M A, Benedetti J K, Jaffe H S, Corey L, A randomized, double-blind, phase I/II trial of tumor necrosis factor and interferon-gamma for treatment of AIDS-related complex (Protocol 025 from the AIDS Clinical Trials Group)., Aids Research and Human Retroviruses, 8(5), 581-7, May 1992 Abstract
  • Kidd P G, Austin G D, Collier A C, Arditti D E, Coombs R W, Corey L, Interference of recombinant soluble CD4 immunoglobulin G in flow cytometric measurement of CD4+ lymphocytes., American Journal of Clinical Pathology, 97(2), 166-9, February 1992 Abstract
  • Collier A C, Marra C, Coombs R W, Claypoole K, Cohen W, Longstreth W T Jr, Townes B D, Maravilla K R, Critchlow C, Murphy V L, et al, Central nervous system manifestations in human immunodeficiency virus infection without AIDS., Journal of Acquired Immune Deficiency Syndromes, 5(3), 229-41, 1992 Abstract
  • Reed S G, da Silva J S, Ho J L, Koehler J K, Russo D M, Pihl D L, Coombs R W, Cytokine activation of human macrophages infected with HIV-1 to inhibit intracellular protozoa., Journal of Acquired Immune Deficiency Syndromes, 5(7), 666-75, 1992 Abstract
  • Celum C L, Coombs R W, Lafferty W, Inui T S, Louie P H, Gates C A, McCreedy B J, Egan R, Grove T, Alexander S, et al, Indeterminate human immunodeficiency virus type 1 western blots: seroconversion risk, specificity of supplemental tests, and an algorithm for evaluation., Journal of Infectious Diseases, 164(4), 656-64, October 1991 Abstract
  • Krieger J N, Coombs R W, Collier A C, Koehler J K, Ross S O, Chaloupka K, Murphy V L, Corey L, Fertility parameters in men infected with human immunodeficiency virus., Journal of Infectious Diseases, 164(3), 464-9, September 1991 Abstract
  • Tartaglione T A, Collier A C, Coombs R W, Opheim K E, Cummings D K, Mackay S R, Benedetti J, Corey L, Acquired immunodeficiency syndrome. Cerebrospinal fluid findings in patients before and during long-term oral zidovudine therapy [published erratum appears in Arch Neurol 1991 Dec;48(12):1238], Archives of Neurology, 48(7), 695-9, July 1991 Abstract
  • Klebanoff S J, Coombs R W, Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission., Journal of Experimental Medicine, 174(1), 289-92, 1 Jul 1991 Abstract
  • Cooney E L, Collier A C, Greenberg P D, Coombs R W, Zarling J, Arditti D E, Hoffman M C, Hu S L, Corey L, Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein [see comments], Lancet, 337(8741), 567-72, 9 Mar 1991 Abstract
  • Watts D H, Brown Z A, Tartaglione T, Burchett S K, Opheim K, Coombs R, Corey L, Pharmacokinetic disposition of zidovudine during pregnancy., Journal of Infectious Diseases, 163(2), 226-32, February 1991 Abstract
  • Krieger J N, Coombs R W, Collier A C, Ross S O, Chaloupka K, Cummings D K, Murphy V L, Corey L, Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy., Journal of Infectious Diseases, 163(2), 386-8, February 1991 Abstract
  • Collier A C, Bozzette S, Coombs R W, Causey D M, Schoenfeld D A, Spector S A, Pettinelli C B, Davies G, Richman D D, Leedom J M, et al, A pilot study of low-dose zidovudine in human immunodeficiency virus infection [see comments], New England Journal of Medicine, 323(15), 1015-21, 11 Oct 1990 Abstract
  • Bowden R A, Coombs R W, Nikora B H, Bigelow C, Sale G E, Thomas E D, Meyers J D, Corey L, Progression of human immunodeficiency virus type-1 infection after allogeneic marrow transplantation., American Journal of Medicine, 88(5N), 49N-52N, May 1990 Abstract
  • Coombs R W, Collier A C, Allain J P, Nikora B, Leuther M, Gjerset G F, Corey L, Plasma viremia in human immunodeficiency virus infection [see comments], New England Journal of Medicine, 321(24), 1626-31, 14 Dec 1989 Abstract
  • Moore D E, Ashley R L, Zarutskie P W, Coombs R W, Soules M R, Corey L, Transmission of genital herpes by donor insemination., Jama, 261(23), 3441-3, 16 Jun 1989 Abstract

Profile Details

Last Updated: 1/11/2008

COS Expertise ID #307402
Reference this profile directly: http://myprofile.cos.com/coombsr02